| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | Director | Common Stock | 17K | $1.3M | $76.26 | Jun 5, 2025 | Direct |
| GERON CORP | Interim President and CEO, Director | Stock Option (right to buy) | 180K | May 21, 2025 | Direct | ||
| CASSAVA SCIENCES INC | Director | Stock Option (Right to Buy) | 53K | Oct 21, 2025 | Direct | ||
| REATA PHARMACEUTICALS INC | Chief Commercial Officer | Class A common stock | 0 | $172.03 | Sep 26, 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Chief Commercial Officer | Class B common stock | 0 | $172.03 | Jul 28, 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Chief Commercial Officer | Employee Stock Option (right to buy) | 0 | $73.68 | Sep 26, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SAVA | CASSAVA SCIENCES INC | Oct 21, 2025 | 1 | $0 | 4 | Oct 22, 2025 | Director |
| SAVA | CASSAVA SCIENCES INC | Oct 21, 2025 | 0 | $0 | 3 | Oct 22, 2025 | Director |
| SLNO | SOLENO THERAPEUTICS INC | Jun 5, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director |
| GERN | GERON CORP | May 21, 2025 | 1 | $0 | 4 | May 22, 2025 | Interim President and CEO, Director |
| SLNO | SOLENO THERAPEUTICS INC | Aug 15, 2024 | 1 | $0 | 4 | Aug 16, 2024 | Director |
| SLNO | SOLENO THERAPEUTICS INC | Aug 15, 2024 | 0 | $0 | 3 | Aug 16, 2024 | Director |
| GERN | GERON CORP | May 9, 2024 | 1 | $0 | 4 | May 10, 2024 | Director |
| RETA | REATA PHARMACEUTICALS INC | Sep 26, 2023 | 9 | $0 | 4 | Sep 26, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Aug 15, 2023 | 2 | -$203K | 4 | Aug 17, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Jul 28, 2023 | 5 | -$5.68M | 4 | Aug 1, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Jul 6, 2023 | 1 | $0 | 4 | Jul 10, 2023 | Chief Commercial Officer |
| GERN | GERON CORP | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| RETA | REATA PHARMACEUTICALS INC | May 15, 2023 | 2 | -$110K | 4 | May 17, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Mar 13, 2023 | 1 | -$808K | 4 | Mar 15, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Mar 6, 2023 | 13 | -$6.61M | 4 | Mar 8, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Mar 3, 2023 | 1 | -$191K | 4 | Mar 6, 2023 | Chief Commercial Officer |
| RETA | REATA PHARMACEUTICALS INC | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Chief Commercial Officer |
| GERN | GERON CORP | May 10, 2022 | 1 | $0 | 4 | May 11, 2022 | Director |
| RETA | REATA PHARMACEUTICALS INC | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Chief Commercial Officer |
| GERN | GERON CORP | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |